ADAMAX 5mg is a research-grade peptide formulation designed for investigation into cognitive enhancement, neuroprotection, and neuroplasticity pathways. The Adamax blend is studied for its potential interactions with glutamatergic signalling and NMDA receptor modulation, mechanisms of significant interest in neuroscience research exploring learning, memory consolidation, and synaptic plasticity.
In preclinical research settings, ADAMAX has been examined for its potential role in supporting neuronal resilience under oxidative stress conditions and its influence on neurotrophic factor expression. These properties make it a compelling candidate for studies into age-related cognitive decline, traumatic brain injury models, and neurodegenerative disease research.
Each vial contains 5mg of ADAMAX supplied as a lyophilised powder, ensuring stability and ease of reconstitution for in vitro and in vivo research protocols. Purity is >98% as confirmed by HPLC analysis.
Storage: Store at -20°C upon receipt. Once reconstituted, store at 4°C and use within 30 days. Avoid repeated freeze-thaw cycles to maintain peptide integrity.
Molecular Formula
N/A
Molecular Weight
N/A
Purity
>98%
CAS Number
N/A
Form
Lyophilised Powder
Research Applications
Cognitive enhancement research, Neuroprotection studies, NMDA receptor modulation, Neuroplasticity research, Neurodegenerative disease models, Synaptic plasticity investigation
For research purposes only. Not for human use.
Reviews
There are no reviews yet.